Compass Therapeutics, Inc. (CMPX) Net earnings per share growth forecast for next year
Compass Therapeutics is attracting leading oncologists to develop antibodies, which influences the trajectory of the consensus earnings per share forecast, as the working chart on GURU.Markets displays via -13.20, capturing the current value of the indicator. The company is creating synergy in immunotherapy, although commercial success depends on FDA verdicts regarding new drugs.
Metric breakdowns and analytics for compasstherapeutics.com (CMPX)
- price and consensus price forecast:
- market capitalization details:
- company book value details:
- company liabilities and liquidity data:
Debt to Equity Compass Therapeutics|CMPX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Compass Therapeutics, Inc.|CMPX - Company Total Indebtedness|Debt to Book Value Compass Therapeutics|CMPX - Amount of Long-Term Liabilities|Company Short-Term Debts Compass Therapeutics|Quick Ratio compasstherapeutics.com
- earnings and market ratios statistics:
CMPX - Company Net Income|Expected Profit Compass Therapeutics|CMPX - Company Value to Net Income|Forward P/E Multiple Compass Therapeutics|CMPX - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Compass Therapeutics|CMPX - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share for the last 12 months Compass Therapeutics|CMPX - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth compasstherapeutics.com|CMPX - Net earnings per share growth this year|Net earnings per share growth forecast for next year Compass Therapeutics
Analysis of all company metrics:Compass Bio
To minimize capital risks, investors assess earnings stability via professional analysts' consensus forecasts. Given the focus of Compass Therapeutics (CMPX) on attracting leading antibody developers, the projected net income per share growth for year n+1 reflects market confidence in the commercialization of preclinical research, allowing a distinction between the long-term fundamental trend and short-term speculative optimism surrounding the company's human capital potential.
Direct competitors
Net earnings per share growth forecast for next year ImmunityBio Corp|Expected earnings per share growth for next year Immunocore Corp (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics (JANX)|Expected earnings per share growth for next year arcusbio.com RCUS|Zymeworks - Expected earnings per share growth for next year|Earnings growth forecast for next year Tango Therapeutics Inc TNGX|IOVA - Net earnings per share growth forecast for next year|IMTX (Immatics Biotechnologies) - Projected earnings per share growth rate for next year|Xencor, Inc. (XNCR) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year replimune.com (REPL)|Expected earnings per share growth for next year LYEL|IPHA - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year PYXS (Pyxis Oncology, Inc.)|Projected earnings per share increase next year CGEN|Earnings growth forecast for next year IOBT (IO Biotech, Inc.)|Expected earnings per share trend next year STRO|MiNK Therapeutics - Earnings growth forecast for next year|Expected net earnings per share growth next year Werewolf Therapeutics|immixbio.com (IMMX) - Net earnings per share growth forecast for next year|ALX Oncology Holdings Inc. - Expected earnings per share trend next year|CUE (Cue Biopharma, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year PDS Biotechnology Corp|Net earnings per share growth forecast for next year Sonnet BioTherapeutics (SONN)|MAIA: Net earnings per share change forecast for next year|Liminatus Pharma Corp - Expected earnings per share growth for next year|LAVA Therapeutics NV (LVTX) - Expected net earnings per share growth next year|NextCure, Inc. - Earnings growth forecast for next year|Leap Therapeutics, Inc. (LPTX) - Expected earnings per share growth for next year|intensitytherapeutics.com (INTS) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Sensei Biotherapeutics, Inc. (SNSE)|Net earnings per share growth forecast for next year Synthetic Biologics|Expected earnings per share growth for next year Gritstone Bio (GRTS)|Net earnings per share growth forecast for next year Kineta, Inc. (KA)|NEXI: Net earnings per share change forecast for next year|Earnings growth forecast for next year TSBX (Turnstone Biologics Corp.)|Earnings growth forecast for next year Vaccinex Inc. VCNX|HARP - Net earnings per share growth forecast for next year
